Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sithara Ramdas
Laurent Servais

Showing results (1-10 of 290) with videos related to

Pageof 29
Sort By:
Expert Opinion on Pharmacotherapy|January 25, 2020
New treatments in spinal muscular atrophy: an overview of currently available dataSithara Ramdas, Laurent Servais
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 11, 2023
Good News Never HurtsSithara Ramdas, Laurent Servais
Drugs|June 15, 2024
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for CliniciansSithara Ramdas, Maryam Oskoui, Laurent Servais
Expert Opinion on Investigational Drugs|March 22, 2022
Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing modifier for spinal muscular atrophy (SMA)Theodora Markati, Gemma Fisher, Sithara Ramdas, et al.
Expert Opinion on Therapeutic Targets|December 16, 2022
Early clinical and pre-clinical therapy development in Nemaline myopathyGemma Fisher, Laurane Mackels, Theodora Markati, et al.
Continuum (Minneapolis, Minn.)|October 2, 2025
Botulism, Lambert-Eaton Myasthenic Syndrome, and Congenital Myasthenic SyndromesSithara Ramdas
Neuromuscular Disorders : NMD|November 5, 2021
Congenital myasthenic syndromes: where do we go from here?Sithara Ramdas, David Beeson
The Lancet. Neurology|February 16, 2024
PROMISE of low-cost immunosuppressants for myasthenia gravisSithara Ramdas, Jacqueline Palace
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2026
Genetic mimics of neuromyelitis optica spectrum disorderSilvia Messina, Sithara Ramdas
Frontiers in Neurology|August 15, 2020
Management of Juvenile Myasthenia GravisKaren O'Connell, Sithara Ramdas, Jacqueline Palace
Pageof 29

Showing results (1-10 of 290) with videos related to

Sort By:
Pageof 29
Expert Opinion on Pharmacotherapy|January 25, 2020
New treatments in spinal muscular atrophy: an overview of currently available dataSithara Ramdas, Laurent Servais
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 11, 2023
Good News Never HurtsSithara Ramdas, Laurent Servais
Drugs|June 15, 2024
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for CliniciansSithara Ramdas, Maryam Oskoui, Laurent Servais
Expert Opinion on Investigational Drugs|March 22, 2022
Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing modifier for spinal muscular atrophy (SMA)Theodora Markati, Gemma Fisher, Sithara Ramdas, et al.
Expert Opinion on Therapeutic Targets|December 16, 2022
Early clinical and pre-clinical therapy development in Nemaline myopathyGemma Fisher, Laurane Mackels, Theodora Markati, et al.
Continuum (Minneapolis, Minn.)|October 2, 2025
Botulism, Lambert-Eaton Myasthenic Syndrome, and Congenital Myasthenic SyndromesSithara Ramdas
Neuromuscular Disorders : NMD|November 5, 2021
Congenital myasthenic syndromes: where do we go from here?Sithara Ramdas, David Beeson
The Lancet. Neurology|February 16, 2024
PROMISE of low-cost immunosuppressants for myasthenia gravisSithara Ramdas, Jacqueline Palace
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2026
Genetic mimics of neuromyelitis optica spectrum disorderSilvia Messina, Sithara Ramdas
Frontiers in Neurology|August 15, 2020
Management of Juvenile Myasthenia GravisKaren O'Connell, Sithara Ramdas, Jacqueline Palace
Pageof 29